M1 Kliniken AG (XTER:M12) ROCE % : 9.35% (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is M1 Kliniken AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. M1 Kliniken AG's annualized ROCE % for the quarter that ended in Jun. 2023 was 9.35%.

M1 Kliniken AG ROCE % Historical Data

The historical data trend for M1 Kliniken AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M1 Kliniken AG ROCE % Chart

M1 Kliniken AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

14.55

18.40

9.09

10.75

7.04

M1 Kliniken AG Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROCE %	Get a 7-Day Free Trial												12.06	8.92	5.63	8.46	9.35

M1 Kliniken AG ROCE % Calculation

M1 Kliniken AG's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	11.061	/	( ( (198.111 - 43.418)	+	(197.025 - 37.466) )	/ 2 )
	=	11.061	/	( (154.693	+	159.559)	/ 2 )
	=	11.061	/	157.126
	=	7.04 %

M1 Kliniken AG's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	14.988	/	( ( (197.025 - 37.466)	+	(203.232 - 42.193) )	/ 2 )
	=	14.988	/	( ( 159.559	+	161.039 )	/ 2 )
	=	14.988	/	160.299
	=	9.35 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

M1 Kliniken AG (XTER:M12) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

M1 Kliniken AG ROCE % Related Terms

Thank you for viewing the detailed overview of M1 Kliniken AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

M1 Kliniken AG (XTER:M12) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M1 Kliniken AG (XTER:M12) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

M12:Germany M12:Germany M12:Germany

Address

Grunauer strasse 5, Berlin, BB, DEU, 12557

Website

https://www.m1-kliniken.de

M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.

Executives

Kilian Brenske	Board of Directors
Attila Strauss	Board of Directors

M1 Kliniken AG (XTER:M12) Headlines

No Headlines